Dasatinib and nilotinib for imatinib-resistant or -intolerant chronic myeloid leukaemia: a systematic review and economic evaluation.

BACKGROUND: Chronic myeloid leukaemia (CML) is a form of cancer affecting the blood, characterised by excessive proliferation of white blood cells in the bone marrow and circulating blood. In the UK, an estimated 560 new cases of CML are diagnosed each year. OBJECTIVES: The purpose of this study was...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Health Technol Assess
Prif Awduron: Rogers, G, Hoyle, M, Thompson Coon, J, Moxham, T, Liu, Z, Pitt, M, Stein, K
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: NIHR Journals Library 2012
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4781389/
https://ncbi.nlm.nih.gov/pubmed/22551803
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3310/hta16220
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg